AB
AVEO

Amalgamated Bank’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Amalgamated Bank’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,537
Closed -$13K – 1820
2019
Q1 		$13K Buy
1,537
+51
+3% +$526 ﹤0.01% 1689
2018
Q4 		$24K Buy
+1,486
New +$32.7K ﹤0.01% 1610
2018
Q3 		– Sell
-1,470
Closed -$33K – 1703
2018
Q2 		$33K Buy
+1,470
New +$34.9K ﹤0.01% 1724

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Amalgamated Bank's AVEO Position: Q2 2019 in Review

Amalgamated Bank sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 1,537 shares — an estimated $13K sold.

Amalgamated Bank first reported a position in AVEO in Q2 2018 and held it in 3 quarters. The position peaked at $33K in Q2 2018. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

  • Amalgamated Bank reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Amalgamated Bank sold 1,537 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $13K.
  • Amalgamated Bank first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
  • Amalgamated Bank's AVEO Pharmaceuticals, Inc. position peaked at $33K in Q2 2018.
  • 73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on Amalgamated Bank's 13F filing for Q2 2019, filed 14 Aug 2019.